Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Viatris Inc.
  6. News
  7. Summary
    VTRS   US92556V1061

VIATRIS INC.

(VTRS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Viatris Wins Court Tussle Against Biogen as US Appeals Court Upholds Earlier Patent Ruling

12/01/2021 | 07:29am EST


© MT Newswires 2021
All news about VIATRIS INC.
01/11Theravance biopharma, inc. announces enrollment of first patient in yupelri phase 4 stu..
AQ
01/06Viatris Lifts Quarterly Dividend 9% to $0.12 Per Share, Payable March 16 to Shareholder..
MT
01/06Viatris Announces 9% Dividend Increase, Fourth Consecutive Quarterly Dividend
PR
01/06Viatris Inc. Announces Dividend Increase, Fourth Consecutive Quarterly Dividend, Payabl..
CI
2021Biocon Biologics Partner Viatris Wins U.S. Court Decisions on Sanofi Appeals for Lantus..
AQ
2021Viatris Confirms Win in Insulin Injection Pen Patent Case Against Sanofi
MT
2021Viatris Wins Court Decisions on Sanofi Appeals of Lantus® Patent Invalidations
PR
2021US Appeals Court Upholds Patent Ruling Invalidating Sanofi's Lantus SoloStar Claims
MT
2021Viatris Pushes Back Investor Event, Reaffirms 2021 Projections;
MT
2021VIATRIS INC.(NASDAQGS : VTRS) added to NASDAQ Biotechnology Index
CI
More news
Analyst Recommendations on VIATRIS INC.
More recommendations
Financials (USD)
Sales 2021 17 884 M - -
Net income 2021 -952 M - -
Net Debt 2021 21 590 M - -
P/E ratio 2021 -18,9x
Yield 2021 2,25%
Capitalization 17 645 M 17 645 M -
EV / Sales 2021 2,19x
EV / Sales 2022 2,09x
Nbr of Employees 38 000
Free-Float 99,7%
Chart VIATRIS INC.
Duration : Period :
Viatris Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VIATRIS INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 14,59 $
Average target price 18,43 $
Spread / Average Target 26,3%
EPS Revisions
Managers and Directors
Michael Goettler Chief Executive Officer & Director
Rajiv Malik President & Director
Sanjeev Narula Chief Financial Officer
Robert J. Coury Executive Chairman
Ramkumar V. Rayapureddy Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
VIATRIS INC.7.83%17 645
JOHNSON & JOHNSON-1.57%443 277
ROCHE HOLDING AG-7.91%306 143
PFIZER, INC.-10.23%297 538
ABBVIE INC.-0.86%237 303
ELI LILLY AND COMPANY-13.89%215 642